← Leaderboards
Jair Lage Siqueira-Neto
University Of California, San Diego
$417,450
Attributed
$1,042,097
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $527.9K · FY2017–19$1M$750K$500K$250K$0
'17
'18
'19
Funding mix
By agency
NIH$1,042,097 · 2
By mechanism
UH2$621,594 · 1
R21$420,503 · 1
Top collaborators
- Sean Ekins3 shared
- Ester Cerdeira Sabino3 shared
- William H Gerwick2 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Elina I Zuniga$19,346,848
- Nathan Claude Gianneschi$7,501,389
Others in their field
Other Emerging Leaders on “Parasitic Diseases”
- Donna Muzny · Baylor College Of Medicine$7,660,082
- Yosuke Kumamoto · Rbhs-New Jersey Medical School$5,977,607
- Jennifer Manuzak · University Of Washington$5,904,701
- Tuan Manh Tran · Indiana University Indianapolis$5,495,892
- Margaret Kane · Biomedical Research Institute$5,348,238
- Kayode K Ojo · University Of Washington$5,283,349
Research focus
Parasitic DiseasesTrypanosoma CruziEfficacy TestingParasitesPharmacologic SubstanceSouth AmericaCharacteristicsEffective TherapyIn VitroMouse ModelPharmaceutical PreparationsBasePlasmaPublishingAcuteCentral AmericaChagas DiseaseDesignChronicInfectionIn VivoLuminescenceAffectBenznidazole
Grant awards (5)
Repurposing pyronaridine as a treatment for Chagas disease$7,630
UH2 · FY2019 · TR
Repurposing pyronaridine as a treatment for Chagas disease$300,277
UH2 · FY2018 · TR
Development of Gallinamide A-Inspired Agents for the Treatment of Chagasâ Disease$227,593
R21 · FY2018 · AI
Repurposing pyronaridine as a treatment for Chagas disease$313,687
UH2 · FY2017 · TR
Development of Gallinamide A-Inspired Agents for the Treatment of Chagasâ Disease$192,910
R21 · FY2017 · AI